Search results
Reality TV star shares battle with postpartum depression as a dad
Good Morning America via Yahoo News· 14 hours agoA reality TV star's decision to talk about his experience as a new dad is shining a light on a...
How to prepare for a second pregnancy after a complicated first one : Life Kit
NPR· 5 hours agoPregnancy complications — like miscarriage, preterm birth or postpartum depression — are incredibly common. But expecting parents can often feel alone if ...
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive via Yahoo Finance· 5 hours agoThe funding will help Reunion pay for a mid-stage study testing its most advanced medicine —...
15 volunteers for new mom — a community tackles postpartum depression in Calgary
CBC via Yahoo News· 3 days agoIn Calgary's northeast, a small non-profit has a unique way to fight postpartum depression and...
An AI blood test purports to diagnose postpartum depression
Washington Post· 3 days agoPostpartum depression is a leading cause of maternal death, but its diagnosis and treatment is spotty at best, negligent at worst. Now San Diego-based start-up ...
Why is a mother’s mental health so important? A doctor explains
WKOW 27 Madison· 21 hours agoToday is World Maternal Mental Health Day, and it’s time to recognize the importance of maternal...
Can Esketamine Prevent Postpartum Depression?
Medscape· 6 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 hour agoReunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the close of a $103 million Series A financing co-led ...
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 2 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum ...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 24 hours agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...